Article Details
Retrieved on: 2019-04-01 21:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>At December 31, 2018, the Alameda, California-based OncoCyte had cash and cash equivalents of $8.0 million and marketable <b>equity securities</b> ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here